2

EBM LIFE CYCLE: MCMC STRATEGIES FOR SYNTHESIS, DEFENSE, AND DENSITY MODELING
Mitch Hill, Jonathan Mitchell, Chu Chen, Yuan Du, Mubarak Shah, Song-Chun Zhu
Cite Source Document DOI
Mutational profiling of myeloid neoplasms associated genes may aid the diagnosis of acute myeloid leukemia with myelodysplasia-related changes
James Yu, Yuan Du, Anum Jalil, Zohaib Ahmed, Shahram Mori, Rushang Patel, Juan Carlos Varela, Chung-Che Chang
Cite Source Document DOI
Mutational profiling of myeloid neoplasms associated genes may aid the diagnosis of acute myeloid leukemia with myelodysplasia-related changes
Adverse Impact of Mutations in DNA Methylation Regulatory Genes on the Prognosis of AML Patients in the 2017 ELN Favorable Risk Group
James Yu, Jingxin Sun, Yuan Du, Rushang Patel, Juan Carlos Varela, Shahram Mori, Chung-Che Chang
Cite Source Document DOI
Adverse Impact of Mutations in DNA Methylation Regulatory Genes on the Prognosis of AML Patients in the 2017 ELN Favorable Risk Group
Comparison of Myeloablative versus Reduced-Intensity Conditioning Regimens in Allogeneic Stem Cell Transplantation Recipients with Acute Myelogenous Leukemia with Measurable Residual Disease-Negative Disease at the Time of Transplantation: A Retrospective Cohort Study
James Yu, Yuan Du, Sarfraz Ahmad, Rushang D Patel, Juan Carlos Varela, Chung-Che Chang, Shahram Mori
Cite Source Document DOI
Comparison of Myeloablative versus Reduced-Intensity Conditioning Regimens in Allogeneic Stem Cell Transplantation Recipients with Acute Myelogenous Leukemia with Measurable Residual Disease-Negative Disease at the Time of Transplantation: A Retrospective Cohort Study
Colon mucosal neoplasia referred for endoscopic mucosal resection: Recurrence of adenomas and prediction of submucosal invasion
At SC1, early recurrence was noted in 77 of 354 (21.8%) lesions; 76 (98.7%) were treated endoscopically. The remaining 277 of 354 (78.2%) lesions had no recurrence at SC1; only 41 lesions (15%) were followed up at SC2. Recurrence at SC2 was found in 4 lesions (9.8%), all of which were treated endoscopically. Lesion size >40 mm was associated with recurrence. Recurrence at both SC1 and SC2 was successfully treated endoscopically in 78 of 81 lesions (96.3%).
Saeed Ali, Neelam khetpal, Evgeny Idrisov, Asad Ur Rahman, Sameen Khalid, Yuan Du, Udayakumar Navaneethan, Shyam Varadarajulu, Robert Hawes, Muhammad Khalid Hasan
Cite Source Document DOI
Colon mucosal neoplasia referred for endoscopic mucosal resection: Recurrence of adenomas and prediction of submucosal invasion
Impact of a Pharmacist-Led Intensive Care Unit Sleep Improvement Protocol on Sleep Duration and Quality
Groups before (n = 48) and after (n = 29) sleep protocol implementation were well matched. After protocol implementation, patients had a longer TST (389 ± 123 vs 310 ± 147 minutes; P = 0.02) and better RCSQ-perceived sleep quality (63 ± 18 vs 42 ± 24 mm; P = 0.0003) compared with before implementation.
Jessica Andrews, Patricia Louzon, Xavier Torres, Eric Pyles, Mahmood H. Ali, Yuan Du, John W. Devlin
Cite Source Document DOI
Impact of a Pharmacist-Led Intensive Care Unit Sleep Improvement Protocol on Sleep Duration and Quality
Prognostic Value of KRAS Mutation Subtypes and PD-L1 Expression in Patients With Lung Adenocarcinoma
KRAS mutation subtype is not associated with patient clinical outcomes or PD-L1 expression status. However, PD-L1 positivity appears to negatively affect OS in LADC patients with G12C mutation. Further study is needed to confirm our observation and to determine if programmed cell death 1/PD-L1 antagonist may affect the clinical outcome of patients with different KRAS mutation subtypes.
Luwei Tao, Ruoyu Miao, Tarek Mekhail, Jingxin Sun, Lingbin Meng, Cheng Fang, Jian Guan, Akriti Jain, Yuan Du, Amanda Allen, Brenda L Rzeszutko, Mark A Socinski, Chung-Che Chang
Cite Source Document DOI
Prognostic Value of KRAS Mutation Subtypes and PD-L1 Expression in Patients With Lung Adenocarcinoma
Colon mucosal neoplasia referred for endoscopic mucosal resection: Recurrence of adenomas and prediction of submucosal invasion
There was overall low prevalence of SMIL in our study. Kudo pit pattern (IIIL + IV and V) and Paris classification 0-IIc were the only factors identified as an independent risk factor for submucosal invasion. The independent risk factor for recurrence was adenoma size (> 40 mm). Almost all recurrences (98.8%) were treated endoscopically.
Mamoon Ur Rashid, Neelam khetpal, Hammad Zafar, Saeed Ali, Evgeny Idrisov, Yuan Du, Assaf Stein, Deepanshu Jain, Muhammad Khalid Hasan
Cite Source Document DOI
Colon mucosal neoplasia referred for endoscopic mucosal resection: Recurrence of adenomas and prediction of submucosal invasion
Characterisation of ICU sleep by a commercially available activity tracker and its agreement with patient-perceived sleep quality
A Fitbit Charge 2 when applied to non-intubated adults in an ICU consistently collects TST data but not
Patricia Louzon, Jessica Andrews, Xavier Torres, Eric Pyles, Mahmood Ali, Yuan Du, John Devlin
Cite Source Document DOI
Characterisation of ICU sleep by a commercially available activity tracker and its agreement with patient-perceived sleep quality
The prognostic value of KRAS mutation subtypes and PD-L1 expression in patients with lung adenocarcinoma
The clinical courses, including tumor stage at diagnosis, presence of brain metastasis, OS and RFS, are similar among lung adenocarcinoma patients with different KRAS mutation subtypes. Additionally, PD-L1 expression status appears to be independent of KRAS mutation subtypes. Of note, concurrent PD-L1 expression and G12C mutation is associated with particularly poorer prognosis. Further study is needed to see if PD1/PD-L1 block may improve outcome of this group of patients.
Luwei Tao, Jingxin Sun, Tarek Mekhail, Lingbin Meng, Yuan Du, Mark A. Socinski, Amanda Allen, Brenda L. Rzeszutko, Chung-Che Chang
Cite Source Document DOI
The prognostic value of KRAS mutation subtypes and PD-L1 expression in patients with lung adenocarcinoma